VALETTI, SABRINA
Distribuzione geografica
Continente | # |
---|---|
NA - Nord America | 537 |
EU - Europa | 238 |
AS - Asia | 201 |
AF - Africa | 7 |
OC - Oceania | 3 |
SA - Sud America | 3 |
Totale | 989 |
Nazione | # |
---|---|
US - Stati Uniti d'America | 517 |
CN - Cina | 122 |
DE - Germania | 55 |
IT - Italia | 55 |
FR - Francia | 38 |
CA - Canada | 18 |
KR - Corea | 18 |
GB - Regno Unito | 17 |
IN - India | 17 |
SE - Svezia | 17 |
PL - Polonia | 12 |
TW - Taiwan | 9 |
VN - Vietnam | 9 |
HK - Hong Kong | 8 |
NL - Olanda | 7 |
ZA - Sudafrica | 6 |
CH - Svizzera | 5 |
UA - Ucraina | 5 |
BE - Belgio | 4 |
CZ - Repubblica Ceca | 4 |
IR - Iran | 4 |
SG - Singapore | 4 |
AU - Australia | 3 |
FI - Finlandia | 3 |
JP - Giappone | 3 |
RU - Federazione Russa | 3 |
CL - Cile | 2 |
ES - Italia | 2 |
HU - Ungheria | 2 |
IE - Irlanda | 2 |
KZ - Kazakistan | 2 |
MX - Messico | 2 |
RO - Romania | 2 |
AT - Austria | 1 |
BR - Brasile | 1 |
DZ - Algeria | 1 |
GR - Grecia | 1 |
ID - Indonesia | 1 |
IQ - Iraq | 1 |
LT - Lituania | 1 |
LU - Lussemburgo | 1 |
MY - Malesia | 1 |
PT - Portogallo | 1 |
QA - Qatar | 1 |
SA - Arabia Saudita | 1 |
Totale | 989 |
Città | # |
---|---|
Fairfield | 68 |
Houston | 51 |
Woodbridge | 47 |
Ashburn | 39 |
Seattle | 34 |
Cambridge | 31 |
Ann Arbor | 27 |
Buffalo | 26 |
Shanghai | 22 |
Wilmington | 21 |
Santa Cruz | 20 |
Torino | 17 |
Beijing | 14 |
Wuhan | 12 |
Orsay | 11 |
Philadelphia | 11 |
Pisa | 8 |
Seoul | 8 |
Taipei | 8 |
Toronto | 8 |
Warsaw | 8 |
Guangzhou | 7 |
Nanjing | 7 |
Dong Ket | 6 |
Shenyang | 6 |
Beaverton | 5 |
Bengaluru | 5 |
Central | 5 |
Las Vegas | 5 |
Muizenberg | 5 |
Nürnberg | 5 |
Phoenix | 5 |
Dallas | 4 |
Malmö | 4 |
Ottawa | 4 |
Rotterdam | 4 |
Zhengzhou | 4 |
Central District | 3 |
Changsha | 3 |
Chengdu | 3 |
Council Bluffs | 3 |
Hangzhou | 3 |
La Jolla | 3 |
Lake Forest | 3 |
London | 3 |
Los Angeles | 3 |
Mountain View | 3 |
New York | 3 |
Oerlikon | 3 |
Rome | 3 |
San Diego | 3 |
University Park | 3 |
Astana | 2 |
Bad Vilbel | 2 |
Ballancourt-sur-Essonne | 2 |
Bhopal | 2 |
Bogen | 2 |
Boulder | 2 |
Brooklyn | 2 |
Caserta | 2 |
Changchun | 2 |
Chaoyang | 2 |
Chungnam | 2 |
Clearwater | 2 |
Dublin | 2 |
Duncan | 2 |
Easton | 2 |
Fargo | 2 |
Gurgaon | 2 |
Helsinki | 2 |
Jacksonville | 2 |
Kraainem | 2 |
La Colle | 2 |
Leawood | 2 |
Modica | 2 |
Mumbai | 2 |
Nyland | 2 |
Palaiseau | 2 |
Qingdao | 2 |
Reims | 2 |
Rennes | 2 |
San Francisco | 2 |
Schorndorf | 2 |
Varsta | 2 |
Wetzlar | 2 |
Airdrie | 1 |
Albuquerque | 1 |
Andover | 1 |
Angers | 1 |
Athens | 1 |
Atlanta | 1 |
Ballarat | 1 |
Bartlesville | 1 |
Bloomfield | 1 |
Boston | 1 |
Brno | 1 |
Brookings | 1 |
Carmel | 1 |
Chandler | 1 |
Charols | 1 |
Totale | 698 |
Nome | # |
---|---|
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor., file e27ce427-ad2c-2581-e053-d805fe0acbaa | 419 |
Peptide conjugation: before or after nanoparticle formation?, file e27ce427-a841-2581-e053-d805fe0acbaa | 308 |
In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better., file e27ce42a-dd56-2581-e053-d805fe0acbaa | 196 |
Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice, file e27ce427-9564-2581-e053-d805fe0acbaa | 117 |
Totale | 1.040 |
Categoria | # |
---|---|
all - tutte | 1.293 |
article - articoli | 0 |
book - libri | 0 |
conference - conferenze | 0 |
curatela - curatele | 0 |
other - altro | 0 |
patent - brevetti | 0 |
selected - selezionate | 0 |
volume - volumi | 0 |
Totale | 1.293 |
Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018/2019 | 73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36 | 37 |
2019/2020 | 236 | 20 | 14 | 12 | 43 | 16 | 23 | 16 | 20 | 25 | 21 | 11 | 15 |
2020/2021 | 174 | 16 | 11 | 14 | 15 | 13 | 14 | 13 | 9 | 13 | 29 | 15 | 12 |
2021/2022 | 258 | 25 | 5 | 19 | 43 | 30 | 15 | 24 | 27 | 7 | 24 | 27 | 12 |
2022/2023 | 113 | 10 | 10 | 24 | 15 | 9 | 10 | 9 | 3 | 15 | 5 | 1 | 2 |
2023/2024 | 11 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 2 | 0 | 0 |
Totale | 1.040 |